Sparking Transformation in Healthcare

egnite is a company with a vision:
to identify and improve outcomes for every cardiovascular patient in the U.S.

Sparking Transformation in Healthcare

egnite is a company with a vision:
to identify and improve outcomes for every cardiovascular patient in the U.S.

Using Big Data to Solve Big Problems   

Advancing the Cardiovascular Health of Our Society

egnite is a digital health company leveraging artificial intelligence-driven algorithms to produce business intelligence for healthcare, elevating the role of data in critical decisions. 

FOR HEALTH PROFESSIONALS   

The CardioCare Platform

Human intelligence enhanced
by artificial intelligence
The Leading Digital Health Platform for Progressive Cardiovascular Centers With Solutions Across Valve Disease Heart Failure Atrial Fibrillation Clinical Trials

FOR LIFE SCIENCES 

egnite Therapy Accelerator & Research

Welcome to one of the largest ecosystems
of real-world cardiovascular data

Podcasts

egnite COO, Jessica Neufeld, discusses the current state of A.I. adoption and challenges in healthcare, along with the role of technology in improving patient care on a recent episode of Microsoft’s Data and A.I. podcast Insights Tomorrow.

egnite Senior Medical Advisor, Rahul Sharma, was recently featured on MedAxiom’s HeartTalk podcast to discuss how technology can be used to identify and treat patients before it’s too late.

Learn more from egnite CEO, Joel Portice, on how egnite is elevating the role of A.I. and big data to guide critical decisions in healthcare on Mike Moore’s The Bleeding Edge of Digital Health podcast.

Real-World Evidence

Presented or Published in

Recognition

Read the Feature

Testimonials

Leading health systems and life sciences organizations partner with egnite to transform care delivery for cardiovascular patients.

CardioCare's A.I. tools will help us ensure that every patient receives optimal evaluation and management of their heart disease. Its big data approach will also help us identify patients who might be candidates for one of many research trials, thereby potentially giving patients access to otherwise unavailable therapeutic options.
Dr. Linda Gillam
Chair of Cardiovascular Medicine
Gagnon Cardiovascular Institute, Morristown Medical Center
This is the first time in my career I've been able to see this type of information for my program. There is always opportunity to improve, even at academic medical institutions. CardioCare is not just a platform; it's a program that can demonstrate value for structural heart programs at every level.
Dr. Rahul Sharma
Associate Professor of Medicine, Stanford University
Director of Structural Interventions, Stanford Health Care
Senior Medical Advisor, egnite

Resources

CRF-TCT
Real-World Evidence

Acute Valve Syndrome in Aortic Stenosis

“These findings are extremely important and complementary to the recently presented EARLY TAVR Trial, published in the NEJM. The absence of symptoms was traditionally considered a sign of relative safety. However, this study shows how frequent acute valve syndrome is in patients undergoing AVR, and how patients would benefit greatly from intervention before symptoms appear.” […]

image000002
Press

egnite Inc.’s Real-World Evidence Demonstrates Improved Survival in Asymptomatic Aortic Stenosis Patients Undergoing Aortic Valve Replacement (AVR)

egnite Inc.’s Real-World Evidence Demonstrates Improved Survival in Asymptomatic Aortic Stenosis Patients Undergoing Aortic Valve Replacement (AVR) Key Findings Demonstrate 3x Improved Survival for Asymptomatic AS Patients Undergoing AVR versus AS Patients Presenting with Acute Valve Syndrome ALISO VIEJO, Calif. – October 28, 2024 – egnite, Inc., a leading cardiovascular digital health company, today announced the […]

IMG_7272
Press

egnite, Inc. and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference

egnite, Inc., a leading digital health company specializing in cardiovascular care, today announced the addition of two distinguished physicians, Vinod H. Thourani, MD and Nicholas Amoroso, MD to its Medical Advisory Board. Their wealth of expertise in cardiovascular care and dedication to innovation will significantly contribute to egnite’s mission to improve cardiovascular patient care nationwide.

Connect with egnite.

Schedule my demo today.